Microvascular endothelial cell (MVEC) apoptosis is considered to be a key event in the pathogenesis of systemic sclerosis (SSc), an increased expression of endothelin-1 (ET1) is also well recognized in the disease. ET1 is thought to exert deleterious effects on the vasculature by virtue of its known vasospastic, proliferative and fibrotic effects, yet ET1 can act as a survival factor for a variety of cells, including MVEC. The aim of this study is to investigate if ET1 signaling protects SSc-MVECs from apoptosis.
Methods
The expression levels of ET1-receptor genes: Endothelin Receptor Type A gene (EDNRA) and Endothelin Receptor Type B gene (EDNRB), and the effects of selective Endothelin Receptor Type A (ETA) antagonists, selective Endothelin Receptor Type B (ETB), and dual ETA/B antagonist in the presence and/or absence of ET1 on control and SSc-MVEC apoptosis were examined.
Results
Significant increase in the expression of ETA and ETB was noted in SSc-MVECs. Growth factors withdrawal (GFW) resulted in a significant apoptosis that was considerably reduced by the addition ET1. The addition of ETA-receptor antagonists did not affect ET1 anti-apoptotic effects, while the nonselective ETA/B or the selective ETB-receptor antagonists blocked the anti-apoptotic effects of ET1. Finally, an upregulation of the proapoptotic gene BAX after GFW was noted that was normalized by the addition of ET1.
Conclusions
The results suggest that ET1 mediates an anti-apoptotic effect through engaging the ETB receptors in MVECs. Therefore, it appears that selective ETA antagonism may have an advantage over the non-selective ET1-receptor antagonists in SSc vasculopathy, particularly in the early stages of the disease when MVEC apoptosis is rampant.
AbrahamDJVargaJScleroderma: from cell and molecular mechanisms to disease models.Trends Immunol2005;26:(11)587-595
2.
SgoncRGruschwitzMSBoeckGSeppNGruberJWickGEndothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.Arthritis Rheum2000;43:(11)2550-2562
3.
BordronADueymesMLevyYet al.The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.J Clin Invest1998;101:(10)2029-2035
4.
WordaMSgoncRDietrichHet al.In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay.Arthritis Rheum2003;48:(9)2605-2614
5.
Shi-WenXDentonCPDashwoodMRet al.Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.J Invest Dermatol2001;116:(3)417-425
6.
HorstmeyerALichtCScherrGEckesBKriegTSignalling and regulation of collagen I synthesis by ET-1 and TGF-beta1.FEBS J2005;272:(24)6297-6309
7.
TabataHYamakageAYamazakiSCutaneous localization of endothelin-1 in patients with systemic sclerosis: immunoelectron microscopic study.Int J Dermatol1997;36:(4)272-275
8.
YamaneKKashiwagiHSuzukiNet al.Elevated plasma levels of endothelin-1 in systemic sclerosis.Arthritis Rheum1991;34:(2)243-244
9.
KadonoTKikuchiKSatoSSomaYTamakiKTakeharaKElevated plasma endothelin levels in systemic sclerosis.Arch Dermatol Res1995;287:(5)439-442
10.
CozzaniEJavorSLaboraiEDroseraMParodiAEndothelin-1 levels in scleroderma patients: a pilot study.ISRN Dermatol2013;2013125632Available from: https://dx-doi-org.web.bisu.edu.cn/10.1155/2013/125632. Accessed Jun 21, 2016.
11.
DavenportAPO'ReillyGKucREEndothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.Br J Pharmacol1995;114:(6)1110-1116
12.
MaguireJJDavenportAPETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.Br J Pharmacol1995;115:(1)191-197
13.
VerhaarMCStrachanFENewbyDEet al.Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.Circulation1998;97:(8)752-756
14.
ClozelMGrayGABreuVLöfflerBMOsterwalderRThe endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo.Biochem Biophys Res Commun1992;186:(2)867-873
15.
ShichiriMKatoHMarumoFHirataYEndothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells.Hypertension1997;30:(5)1198-1203
16.
ShichiriMMarumoFHirataYEndothelin-B receptor-mediated suppression of endothelial apoptosis.J Cardiovasc Pharmacol1998;31Suppl 1S138-S141
17.
MiasiroNKarakiHMatsudaYPaivaACRaeGAEffects of endothelin ET(B) receptor agonists and antagonists on the biphasic response in the ileum.Eur J Pharmacol1999;369:(2)205-213
18.
KarakiHSudjarwoSAShimamotoNWakimasuMFujinoMEffects of a potent, non-selective endothelin receptor antagonist, [Thr18, gamma-MeLeu19]-endothelin-1, on the isolated blood vessels.Biochem Biophys Res Commun1995;212:(2)421-427
19.
CardellLOUddmanREdvinssonLA novel ETA-receptor antagonist, FR 139317, inhibits endothelin-induced contractions of guinea-pig pulmonary arteries, but not trachea.Br J Pharmacol1993;108:(2)448-452
20.
MaguireJJKucREDavenportAPDefining the affinity and receptor sub-type selectivity of four classes of endothelin antagonists in clinically relevant human cardiovascular tissues.Life Sci2012;9113-14681-686
21.
BolliMHMarfurtJGrisostomiCet al.Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonists.J Med Chem2004;47:(11)2776-2795
22.
OpitzCFEwertRKirchWPittrowDInhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Eur Heart J2008;29:(16)1936-1948
23.
van den HoogenFKhannaDFransenJet al.2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.Ann Rheum Dis2013;72:(11)1747-1755
24.
WangYKahalehBEpigenetic repression of bone morphogenetic protein receptor II expression in scleroderma.J Cell Mol Med2013;17:(10)1291-1299
25.
WangYFanPSKahalehBAssociation between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.Arthritis Rheum2006;54:(7)2271-2279
26.
TritzRMuellerBMHickeyMJet al.siRNA down-regulation of the PATZ1 gene in human glioma cells increases their sensitivity to apoptotic stimuli.Cancer Ther2008;6B865-876Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600477. Accessed Jun 21, 2016.
27.
YanagisawaMKuriharaHKimuraSet al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature1988;332:(6163)411-415
28.
GoracaANew views on the role of endothelin (minireview).Endocr Regul2002;36:(4)161-167
29.
PaolilloMRussoMACurtiDLanniCSchinelliSEndothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells.Pharmacol Res2010;61:(4)306-315
30.
LahavRHeffnerGPattersonPHAn endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo.Proc Natl Acad Sci USA1999;96:(20)11496-11500
31.
SakaiSMaruyamaHKimuraTet al.Antagonists to endothelin receptor type B promote apoptosis in human pulmonary arterial smooth muscle cells.Life Sci2016
32.
KahalehMBEndothelin, an endothelial-dependent vasoconstrictor in scleroderma.Enhanced production and profibrotic action. Arthritis Rheum1991;34:(8)978-983
33.
VancheeswaranRAzamABlackCDashwoodMRLocalization of endothelin-1 and its binding sites in scleroderma skin.J Rheumatol1994;21:(7)1268-1276
34.
FleischmajerRPerlishJSWestWPUltrastructure of cutaneous cellular infiltrates in scleroderma.Arch Dermatol1977;113:(12)1661-1666
35.
SgoncRGruschwitzMSDietrichHRecheisHGershwinMEWickGEndothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.J Clin Invest1996;98:(3)785-792
36.
VauxDLCorySAdamsJMBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.Nature1988;335:(6189)440-442
37.
KarsanAYeeEHarlanJMEndothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1.J Biol Chem1996;271:(44)27201-27204
38.
SomervailleTCLinchDCKhwajaAGrowth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax.Blood2001;98:(5)1374-1381
39.
KingARFrancisSEBridgemanCJBirdHWhyteMKCrossmanDCA role for caspase-1 in serum withdrawal-induced apoptosis of endothelial cells.Lab Invest2003;83:(10)1497-1508
40.
DongFZhangXWoldLERenQZhangZRenJEndothelin-1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1.Br J Pharmacol2005;145:(3)323-333
41.
AbrahamDJVancheeswaranRDashwoodMRet al.Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.Am J Pathol1997;151:(3)831-841
42.
EvansNJWalkerJWEndothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization.Biophys J2008;95:(1)483-492
43.
GreganBJürgensenJPapsdorfGet al.Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers.J Biol Chem2004;279:(26)27679-27687
44.
WattsSWEndothelin receptors: what's new and what do we need to know?Am J Physiol Regul Integr Comp Physiol2010;298:(2)R254-R260
